文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症患者蛋白质治疗有效性评估:统计学缺陷在解释观察性研究与随机对照试验差异中的作用

Assessment of the effectiveness of protein in critical illness: the role of statistical shortcomings in explaining discrepancies between observational studies and randomized controlled trials.
PubMed 文献 · Crit Care · 2026-08-22
一句话结论多项统计偏倚可能夸大了旧观察性研究中高蛋白摄入的获益,从而解释其与近年RCT(EFFORT Protein、PRECISe、TARGET Protein)结果不一致。

本文为综述,聚焦重症患者蛋白质处方推荐所依据的证据。2009–2017年多项大型多中心非随机干预研究一致报告急性期较高蛋白摄入与较低死亡率相关;但2023年EFFORT Protein、2024年PRECISe、2025年TARGET Protein等大型RCT未发现增加蛋白质给药的临床获益。作者识别出观察性营养研究中多种统计偏倚,包括时间轴违背、适应证混杂、未考虑洗入期、变量选择与数值混杂变量建模不当、转移偏倚、样本量偏倚、竞争风险偏倚、非随机缺失偏倚、不死时间偏倚和碰撞偏倚。作者建议现代观察性研究应模拟RCT设计,采用竞争风险模型、时变分析、非线性建模和滞后时间调整等高级统计方法,并强调严格的统计规划、透明分析协议和专家统计审查。

要点

  • 2023年EFFORT Protein、2024年PRECISe、2025年TARGET Protein等大型RCT均未发现增加蛋白质给药的临床获益。
  • 2009–2017年多项大型多中心非随机干预研究曾一致报告急性期较高蛋白摄入与较低死亡率相关。
  • 作者识别出观察性营养研究中多种统计偏倚,包括时间轴违背、适应证混杂、未考虑洗入期、不死时间偏倚和碰撞偏倚等。
  • 现代观察性研究应模拟RCT设计,采用竞争风险模型、时变分析、非线性建模和滞后时间调整等高级统计方法。
  • 严格的统计规划、透明分析协议和专家统计审查是确保观察性营养研究产生有效、临床有意义证据的必要条件。

适用人群与场景

  • 原文未提及

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 本文为综述,未报告原始研究样本量、中心数或效应量;文中汇总指出2009–2017年多项大型多中心非随机干预研究一致报告急性期较高蛋白摄入与较低死亡率相关,而2023年EFFORT Protein、2024年PRECISe、2025年TARGET Protein等大型RCT未发现增加蛋白质给药的临床获益。

证据类型、等级与局限

  • 证据类型为综述;原文未给出证据等级或推荐强度;局限为未报告系统检索策略、未提供纳入研究的具体样本量与效应量,结论基于叙述性汇总。

对床旁实践的改变

  • 提示急诊/ICU医生在解读观察性营养研究(如高蛋白摄入与死亡率关联)时应警惕时间轴违背、适应证混杂、不死时间偏倚等统计缺陷,不宜仅凭观察性研究结果常规提高重症患者蛋白质处方量;原文未提及具体适用与不适用人群及药物剂量调整。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Until 2023, recommendations for prescribing protein to critically ill patients were largely based on observational studies and non-randomized interventions. Several large, multicentre non-randomized studies of intervention conducted between 2009 and 2017 consistently reported that higher protein intake during the acute phase of critical illness was associated with lower mortality. However, major randomized controlled trials published in recent years (the EFFORT Protein trial in 2023, the PRECISe trial in 2024, and the TARGET Protein trial in 2025) have found no clinical benefit of increased protein administration. The reasons for these conflicting results are unclear, but they may be related to statistical shortcomings in observational studies.

MAIN BODY: The authors identified numerous types of statistical bias in observational nutrition research. These include violations of the time axis, confounding by indication, failure to account for a wash-in period, inappropriate methods for variable selection and modelling of numerical confounder variables, transfer bias, sample-size bias, competing-risk bias, bias by data not missing at random, immortal time bias, and collider bias. To improve reliability, modern observational studies should emulate the design of randomized controlled trials. Advanced statistical approaches, including competing-risk models, time-varying analyses, nonlinear modelling and lag-time adjustments, can better account for the complexity of nutrition therapy in critical illness.

CONCLUSIONS: Numerous types of bias may have exaggerated the apparent benefits of higher protein intake in older observational studies possibly explaining discrepancies to newer randomized trials. Rigorous statistical planning, transparent analysis protocols, use of advanced statistical approaches and expert statistical review are required to ensure that observational nutrition research produces valid, clinically meaningful evidence.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Neuberger M, Hartl WH. Assessment of the effectiveness of protein in critical illness: the role of statistical shortcomings in explaining discrepancies between observational studies and randomized controlled trials. Crit Care. 2026. PMID: 42642764. doi:10.1186/s13054-026-06273-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。